PATIENT EDUCATION

Brain Arteriovenous Malformations (AVM)

Arteriovenous malformations (AVM) are congenital vascular anomalies in which arteries connect directly to veins without an intervening capillary bed. This “shortcut” creates a high-flow circulation and increases the risk of intracranial hemorrhage.

The Neuroknife team specializes in diagnosis, individualized risk stratification, and comprehensive AVM treatment using a tailored combination of microsurgery, endovascular embolization, and stereotactic radiosurgery—aligned with leading international standards and academic protocols (Harvard, Mayo Clinic, UCSF).

Annual hemorrhage risk: 1–2% Higher after prior rupture Patient-specific risk modifiers Surgery and/or embolization when appropriate

You’ve been diagnosed with an AVM — what does that mean?

An AVM is a congenital vascular anomaly—meaning you are born with it. It is not cancer. The primary concern, however, is intracranial hemorrhage.

Each AVM must be evaluated on its own terms: size, location, venous drainage pattern, presence of an intranidal aneurysm, prior hemorrhage, and other individualized features.

What is an arteriovenous malformation?

It is an abnormal “tangle of vessels” (the nidus) in which arteries connect directly to veins without a capillary network, leading to:

  • high-flow hemodynamics
  • venous dilation
  • risk of rupture and hemorrhage

Why does an AVM form? Causes & genetic considerations

Most AVMs are congenital (present from birth). Unlike cavernous malformations, AVMs typically do not follow a clear inherited genetic pattern.

Features that can increase hemorrhage risk include:

  • Prior hemorrhage (the strongest predictor of future bleeding)
  • Intranidal aneurysm
  • Deep anatomical location
  • Exclusive deep venous drainage
  • Venous outflow stenosis
  • Small nidus size (potentially associated with higher intranidal pressure)

Symptoms & hemorrhage risk

AVMs may be entirely asymptomatic or present with:

  • Hemorrhage (rupture) — the most common first presentation
  • Seizures
  • Headache, focal or migraine-like
  • Neurologic deficits

Annual hemorrhage risk

  • ~1–2% per year for unruptured AVMs without high-risk features
  • ~5–10% per year when high-risk features are present
  • >10% per year after a prior hemorrhage

Lifetime cumulative hemorrhage risk can be approximated by: 1 – (1 – R)L where R = annual risk and L = years of life expectancy.

How is an AVM diagnosed?

A complete AVM workup commonly includes:

  • Brain MRI — defines the nidus and detects prior hemorrhage
  • CTA — rapid vascular imaging
  • DSA (digital subtraction angiography) — the gold standard:
    • Characterizes arterial feeders
    • Identifies fistulas and venous drainage patterns
    • Detects intranidal aneurysms

When is treatment necessary?

The decision is individualized and based on hemorrhage risk, age, Spetzler–Martin grade, symptoms, and anatomical accessibility.

Common indications for treatment

  • Prior hemorrhage
  • Intranidal aneurysm
  • Seizures not adequately controlled with medication
  • New or progressive neurologic symptoms
  • Low-grade AVMs (Spetzler–Martin I–III)

When observation may be preferred

  • High-grade, unruptured AVMs (Spetzler–Martin IV–V)
  • Patients with a high procedural/surgical risk profile

Treatment options

1) Endovascular embolization

  • Flow reduction or cure in selected cases
  • Preoperative adjunct to improve microsurgical safety
  • Treatment of an intranidal aneurysm or high-risk weak point

2) Microsurgical AVM resection

The definitive option for many low-grade AVMs.

  • Immediate eradication of the nidus
  • Eliminates future hemorrhage risk once confirmed cured

3) Stereotactic radiosurgery (SRS)

  • Best suited for small to medium AVMs
  • Gradual obliteration over ~2–3 years

4) Combined (multimodality) therapy

Many AVMs require a staged combination of embolization plus microsurgery or SRS, to achieve safer and more effective durable treatment.

What should I expect in the hospital?

  • Pre-treatment DSA and high-resolution MRI planning
  • Neuronavigation and advanced microsurgical technique where indicated
  • Observation in a high-dependency unit or ICU for 24–48 hours when appropriate
  • Stepwise return to activity with individualized guidance

Recovery & long-term prognosis

Prognosis depends on:

  • Spetzler–Martin grade
  • Whether hemorrhage has occurred
  • Success in achieving complete nidus obliteration
  • Any neurologic deficits present before treatment

Daily life & restrictions

  • Avoid activities with a meaningful risk of head injury
  • Optimize blood pressure control
  • Driving restrictions may apply in patients with seizures
  • Regular exercise is often acceptable in stable AVMs, with individualized guidance

When is it an emergency?

  • Sudden, severe “worst headache of life”
  • New weakness on one side, numbness, gait instability
  • A new seizure
  • Sudden confusion or loss of consciousness

What should I ask my neurosurgeon?

Suggested questions
  • What is my true annual and lifetime cumulative hemorrhage risk?
  • What is my AVM’s Spetzler–Martin grade?
  • Are there high-risk features (aneurysms, deep venous drainage, venous stenosis)?
  • Which treatment strategy do you recommend—and why?
  • What is the expected cure/complete obliteration rate in my case?

Need a second opinion for an AVM?

The Neuroknife team provides comprehensive review, individualized risk stratification, and advanced treatment pathways in microsurgery, embolization, and stereotactic radiosurgery.

Send us your imaging for review
Book Appointment Contact